Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000503716 | SCV000595269 | likely pathogenic | Muscular dystrophy-dystroglycanopathy | 2016-06-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000688977 | SCV000816610 | pathogenic | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7; Autosomal recessive limb-girdle muscular dystrophy type 2U | 2023-12-12 | criteria provided, single submitter | clinical testing | This variant, c.277_279del, results in the deletion of 1 amino acid(s) of the ISPD protein (p.Ile93del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs397515398, gnomAD 0.008%). This variant has been observed in individual(s) with clinical features of Walker-Warburg syndrome (PMID: 2522420; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 31564). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. For these reasons, this variant has been classified as Pathogenic. |
Revvity Omics, |
RCV000300802 | SCV002016722 | likely pathogenic | not provided | 2022-04-07 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000024272 | SCV000045563 | pathogenic | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7 | 2012-05-01 | no assertion criteria provided | literature only | |
Eurofins Ntd Llc |
RCV000300802 | SCV000340809 | uncertain significance | not provided | 2016-04-27 | flagged submission | clinical testing |